Gene · 4017
Papers2,536
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 2,536
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Liquid Biopsy and Circulating Biomarkers for the Diagnosis of Precancerous and Cancerous Oral Lesions. | Noncoding RNA | 2022 | 36005828 | PubTator, text mining | PubMed |
| Full-length dystrophin deficiency leads to contractile and calcium transient defects in human engineered heart tissues. | J Tissue Eng | 2022 | 36003954 | PubTator, text mining | PubMed |
| Identification of novel early pancreatic cancer biomarkers KIF5B and SFRP2 from "first contact" interactions in the tumor microenvironment. | J Exp Clin Cancer Res | 2022 | 36002889 | PubTator, text mining | PubMed |
| Common Variants Near ZIC1 and ZIC4 in Autopsy-Confirmed Multiple System Atrophy. | Mov Disord | 2022 | 35997131 | PubTator, text mining | PubMed |
| Novel estrogen-responsive genes (ERGs) for the evaluation of estrogenic activity. | PLoS One | 2022 | 35976950 | PubTator, text mining | PubMed |
| Biochemical and molecular alterations and potential clinical applications of biomarkers in keratoconus. | Saudi J Ophthalmol | 2022 | 35971485 | PubTator, text mining | PubMed |
| Potential roles of non-lymphocytic cells in the pathogenesis of IgG4-related disease. | Front Immunol | 2022 | 35967331 | PubTator, text mining | PubMed |
| The cancer-associated fibroblast-related signature predicts prognosis and indicates immune microenvironment infiltration in gastric cancer. | Front Immunol | 2022 | 35967313 | PubTator, text mining | PubMed |
| In silico development and validation of a novel glucose and lipid metabolism-related gene signature in gastric cancer. | Transl Cancer Res | 2022 | 35966316 | PubTator, text mining | PubMed |
| Inhibitory effects of LOXL2 knockdown on cellular functions of liver cancer stem cells. | Transl Cancer Res | 2022 | 35966289 | PubTator, text mining | PubMed |
| Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH). | Signal Transduct Target Ther | 2022 | 35963848 | PubTator, text mining | PubMed |
| METTL3 inhibits inflammation of retinal pigment epithelium cells by regulating NR2F1 in an m6A-dependent manner. | Front Immunol | 2022 | 35936005 | PubTator, text mining | PubMed |
| Research Progress in the Molecular Mechanisms, Therapeutic Targets, and Drug Development of Idiopathic Pulmonary Fibrosis. | Front Pharmacol | 2022 | 35935869 | PubTator, text mining | PubMed |
| Endothelial cell-derived extracellular vesicles impair the angiogenic response of coronary artery endothelial cells. | Front Cardiovasc Med | 2022 | 35928931 | PubTator, text mining | PubMed |
| Interplay Between Immune and Cancer-Associated Fibroblasts: A Path to Target Metalloproteinases in Penile Cancer. | Front Oncol | 2022 | 35928876 | PubTator, text mining | PubMed |
| GDNF Promotes Astrocyte Abnormal Proliferation and Migration Through the GFRα1/RET/MAPK/pCREB/LOXL2 Signaling Axis. | Mol Neurobiol | 2022 | 35925441 | PubTator, text mining | PubMed |
| Proteome and phosphoproteome signatures of recurrence for HPV+ head and neck squamous cell carcinoma. | Commun Med (Lond) | 2022 | 35919862 | PubTator, text mining | PubMed |
| Combining Immune-Related Genes For Delineating the Extracellular Matrix and Predicting Hormone Therapy and Neoadjuvant Chemotherapy Benefits In Breast Cancer. | Front Immunol | 2022 | 35911730 | PubTator, text mining | PubMed |
| Hub Genes Identification, Small Molecule Compounds Prediction for Atrial Fibrillation and Diagnostic Model Construction Based on XGBoost Algorithm. | Front Cardiovasc Med | 2022 | 35911532 | PubTator, text mining | PubMed |
| Copper in the tumor microenvironment and tumor metastasis. | J Clin Biochem Nutr | 2022 | 35903604 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4017/papers?page=34